_________________________________ 4. NEWS: Tanzania’s TB/HIV funding request to the Global Fund yields three grants Funding request identifies vulnerable groups for TB Kataisee Richardson 6 March 2018 Mainland Tanzania submitted a funding request for its HIV and TB components that resulted in the Global Fund Board approving three grants, including a TB/HIV grant to a civil society principal recipient (PR) –– AMREF Health Africa. The Ministry of Finance and Planning (MOFP) was awarded an HIV grant and a TB grant. Tanzania is one of the countries in sub-Saharan Africa most heavily impacted by HIV and TB. The HIV prevalence among adults aged 15–49 was estimated at 5.3% in 2012, which nevertheless represents a steady decline from 7% in 2003. HIV prevalence is highest among key populations. These include men who have sex with men (MSM), people who inject drugs (PWID), and sex workers, whose rates are estimated at 25%, 36% and 26%, respectively. Data suggests that HIV infection rates begin to rise much earlier in girls than boys, creating a need to provide age-tailored prevention services to adolescent girls. Significant strides have been made to address vertical transmission of HIV with near universal antiretroviral therapy (ART) coverage of HIV-infected pregnant women. Tanzania ranks 6th globally in terms of its TB and TB/HIV burdens. The prevalence of TB is estimated by the World Health Organization (WHO) to be 528 per 100,000, with treatment coverage of only 37%, making it particularly critical for the National TB Program to identify and treat the missing TB cases. Tanzania’s allocation for 2017–2019 was $579.6 million. The indicative breakdown of the allocation was as follows: HIV –– $408.5 million TB –– $25.8 million Malaria –– $145.3 million Total –– $579.6 million After Tanzania moved $43.5 million from HIV to malaria to cover resilient and sustainable systems for health (RSSH) activities, and made additional minor adjustments, the final approved program split was as follows: HIV –– $364.3 million TB –– $26.5 million Malaria –– $188.8 million Total –– $579.6 million
complete with indicators. The evaluators also recommended that the complement of staff be increased. The evaluation report provided the following information on the 5% Initiative’s Channel 1: From 2011 to 2016, 280 missions have been implemented (around 60 per year) totaling € 22.2 million –– 23% of the 5% Initiative’s budget over the period. These missions target mainly health system issues (47% of the missions) such as national disease program strengthening, support to national health information systems, and improvement of drug procurement and supply management. Support for country dialogues and applying for funding represented 28% of the missions. In terms of geographic area, 47% of the missions are deployed in West Africa, 18% in Central Africa and 15% in Asia. Of the funds spent, 33% benefited country coordinating mechanisms, 26% principal recipients, 21% sub recipients and 20% others (such as national programs, health ministries, public procurement agencies, local NGOs and regional organizations). The report provided the following information on Channel 2: From 2011 to 2016, 69 projects have been granted for a total amount of € 79.4 million, 63% of the 5% Initiative’s budget. Through Channel 2, the projects funded target mostly HIV (50% of the projects). Other projects dealt with health systems strengthening (29%), malaria (12%) and TB (9%). Projects are led and implemented by four types of stakeholders: international NGOs (46%), research institutes or universities (23%), local NGOs (18%) and public organizations (13%). In terms of geographic area, 64% of the projects are deployed in West Africa, 15% in Central Africa and 12% in Asia (but many projects concern multiple countries and are difficult to classify). Do you have any reaction to this article (or any article in GFO)? To send a note to the editor, just click . We value your feedback. _________________________________
Table 2: 2017-2019 Multi-country grants information Disease Sub-priority Application approach (# of grants) Expected submission timing Sub-priority funding ceiling ($ million) Malaria 1. Elimination of malaria in Mesoamerica and Hispaniola Pre-ID (1) Complete 6.0 m 2. Elimination of malaria in South Africa Pre-ID (1-2) Apr 2018 or later 20.0 m 3. Elimination of malaria multi-drug resistance in Greater Mekong (RAI) * Pre-ID (1) Complete; being impl. 119.0 m TB 4. TB in mining, Southern Africa Pre-ID (1) Complete; being impl. 22.5 m 5. Supranational labs in Eastern and Southern Africa Pre-ID (1) Apr or Aug 2018 4.5 m 6. Improving quality of care and prevention for MDR-TB in Eastern Europe () RFP (1) Apr 2018 5.0 m 7. Support LAC countries transitioning from Global Fund TB funding RFP (1) Aug 2018 4.5 m 8. Interventions among refugees in East Africa () RFP (1) Apr 2018 7.5 M 9. Supranational lab in Western and Central Africa () RFP (1) Apr 2018 6.0 M 10. TB/MDR-TB interventions mobile pop. in Asia; Afghan () and Greater Mekong () 2 RFPs (2) Apr 2018 5.0 m Afghan; 10.0 m Mekong HIV 11. Sustainability of service for KPs in LAC region 2 RFPs (2-3) Aug 2018 10.5 m LAC; 6.5 m Carib. 12. Sustainability of service for KPs in EECA region () RFP (1-2) Apr 2018 13.0 m 13. Sustainability of service for KPs in Southeast Asia region Pre-ID (1) Aug 2018 12.5 m 14. Sustainability of service for KPs in MENA region () RFP (1) Apr 2018 7.5 m * Note: The RAI grant is a hybrid. It includes funding from the multi-country budget ($119 million) and funding from country allocations ($124.7 million). For details on each sub-priority, please see the Global Fund’s .
Table 3. Sub-Saharan Africa regional grants Disease Grant title Principal recipient End date Countries included Malaria Lubombo Spatial Dev. Initiative 2 Dec 2019 Mozambique, South Africa, Swaziland Malaria (Elimination 8) Non-Profit Association "Southern Africa Malaria Elimination Eight Initiative Sect." Sep 2018 Botswana, Swaziland, Namibia, South Africa, Angola, Mozambique, Zambia, Zimbabwe TB/HIV Intergovernmental Authority on Development Mar 2019 Djibouti, Ethiopia, Kenya, Somalia, Sudan, South Sudan and Uganda TB/HIV RO Alliance Nationale Contre le Sida (ANCS) Dec 2019 Sénégal, Burkina Faso, Cape Verde, Côte d’Ivoire and Guinea Bissau TB East, Central and Southern Africa Health Community Oct 2019 Botswana, Burundi, Eritrea, Kenya, Lesotho, Malawi, Mauritius, Mozambique, Namibia, Rwanda, Seychelles, Somalia, S. Sudan, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe HIV International Treatment Preparedness Coalition Dec 2019 Benin, C.I., Gambia, Ghana, Guinea, Guinea-B., Liberia, Mali, Sénégal, Sierra Leone, Togo HIV Handicap International Federation Dec 2019 B. Faso, Cape Verde, Niger, Mali, Sénégal HIV African Network for the Care of Children Affected by HIV/AIDS Oct 2018 Burundi, Ethiopia, Malawi, Nigeria, South Sudan, Tanzania, Uganda HIV Humanist Institute for Co-op. with Developing Countries (HIVOS) Dec 2018 Botswana, Lesotho, Malawi, Namibia, South Africa, Swaziland, Zambia, Zimbabwe HIV UNDP Dec 2018 Botswana, C.I., Kenya, Malawi, Nigeria, Sénégal, Seychelles, Tanzania, Uganda, Zambia HIV Kenya AIDS NGOs Consortium Sep 2018 Burundi, Ethiopia, Kenya, Mauritius, Seychelles, Tanzania (including Zanzibar), Uganda HIV Abidjan-Lagos Corridor Organization Dec 2018 Côte d’Ivoire, Ghana, Togo, Benin, Nigeria